Insider Sale: Director at $ACTG Sells 16,000 Shares

Director Isaac T. Kohlberg sold 16,000 shares of $ACTG on June 11, 2025, for approximately $61,440, representing roughly 15.8% of their holdings in that class of stock. Over the past six months, $ACTG insiders have engaged in three open market transactions: two purchases by the General Counsel and CEO, and the aforementioned sale by Kohlberg. Recent institutional activity shows mixed sentiment, with JPMorgan Chase increasing its position by 639.2% while Royce & Associates reduced its stake by 69.5%.

Analysis

A director at Acacia Research Corporation ($ACTG), Isaac T. Kohlberg, recently sold 16,000 shares on June 11, 2025, for an estimated $61,440, a divestment representing approximately 15.8% of his holdings in that specific class of stock. Following this transaction, Kohlberg retains 85,446 shares. This sale is juxtaposed with recent insider buying activity over the past six months, which includes purchases by General Counsel Jason W. Soncini (7,000 shares for ~$26,523) and Chief Executive Officer Martin D. Jr. McNulty (5,300 shares for ~$19,981), totaling two purchases against this one sale. Institutional ownership trends for $ACTG indicate a net decrease, with 63 firms reducing their positions compared to 33 adding shares in the most recent quarter. Significant institutional selling activity in Q1 2025 includes Royce & Associates LP cutting its stake by 69.5% (816,501 shares), Goldman Sachs Group Inc reducing by 63.8% (351,902 shares), and Brandywine Global Investment Management, LLC decreasing by 88.5% (209,756 shares). Additionally, Acuitas Investments, LLC completely exited its position in Q4 2024 (472,566 shares). In contrast, JPMorgan Chase & Co significantly increased its holding by 639.2% (631,814 shares) in Q1 2025, and Peapod Lane Capital LLC boosted its position by 82.9% (197,268 shares). The overall sentiment score for $ACTG is mildly negative at -0.25, reflecting the director's sale and the broader institutional selling, despite the CEO/GC purchases and concentrated institutional buying from entities like JPMorgan.

Key Decisions for Investors

• Investors should critically evaluate the director's substantial partial sale against the context of recent stock purchases by the company's CEO and General Counsel to form a comprehensive view of insider sentiment.
• Given that more institutional investors (63) decreased their positions in $ACTG than increased them (33) in the latest quarter, upcoming institutional holding reports should be closely monitored to ascertain if this net selling trend continues or reverses.
• The starkly contrasting major institutional activities, such as Royce & Associates' significant divestment versus JPMorgan Chase's large accumulation, warrant further investigation into the respective investment theses to understand potential underlying factors influencing these decisions.
• The combination of a director's sale, net institutional selling, and a mildly negative sentiment score suggests a cautious approach may be prudent; investors should review their positions in $ACTG relative to their risk tolerance and monitor for further signals that could clarify the company's near-term outlook.